Introduction to the American cancer society workshop on psa: Benefits and limitationsNo abstract is available for this article.doi:10.1002/1097-0142(19930415)71:8<2677::aid-cncr2820710838>3.0.co;Gerald P. MurphyRobert V. P. HutterCancer
Prostate cancer is an important health problem in men. It rarely causes death in men younger than 50 years; most deaths associated with it occur in men older than 75 years. The benefits of screening with the prostate-specific antigen (PSA) test are outweighed by the harms for most men. ...
Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA). Prostate cancer is one of the most common forms of noncutaneous cancer in men in the United States. Despite its prevalence, the natural history of this disease is remarkably heterogeneous. In many patients...
Comparability of health-related quality of life (HRQOL), treatment decision making, and treatment satisfaction after PSA recurrence among prostate cancer patients who receive hormone therapy (HT) versus observation (OBS): Results from th... HT may lower PSA, but it may also cause hot flashes and...
The screening guidelines currently used by the US Preventive Services Task Force have noted that PSA screenings can begin to be conducted at 55 years of age for all patients. However, other medical societies, such as the National Comprehensive...
iFluor 440 Styramide价格:￥3612/支产品详情:简要概述 Power Styramide 信号放大(PSA)系统是可以检测细胞和组织中极低丰度靶标最灵敏的方法之一,其荧光信号强度比广泛... 纯度:98% 包装规格:100 Slides 用途:Research Grade 货号:CS44900 品牌:AAT Bioquest ...
One example of a diagnostic which uses exosomes is a prostate test. This exosome-based diagnostic is used to rule out patients who don’t need a biopsy of the prostate, and is performed in male patients with slightly elevated PSA. The test uses urine as the source ma...
SER’s employer receives research grants from Bayer, and she is a consultant to or advisory board member of Bayer, Reata Pharmaceuticals, and Relypsa. She is the president-elect of the National Kidney Foundation. PR has received research support from Astellas Pharma, AstraZeneca, Bayer, ...
ambiguous PSA test result, thereby reducing complications from unnecessary and invasive procedures. The ExoDx Prostate is the leading test for at-home collection, enabling thousands of patients unable to travel to their healthcare professional for a routine office visit to assess prostate cancer risk....
So the ACP, internal medicine specialists, reviewed leading cancer screening guidelines to find the least intensive testing strategies with the broadest expert consensus. Dr. Richard Wender of the American Cancer Society said even though it disagrees on some specifics, emphasizing areas of ...